Apricot Capital
Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Apricot Capital Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics. Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in the healthcare industry. Its professional background includes life sciences, medicine, finance and law.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 6/2020 | Immvira | Series B | 58M |
| 8/2020 | Jabrehoo Med Tech | Series B | 14.4M |
| 1/2019 | Jousing Medical | Series A | 0 |
| 9/2018 | Bellen Chemistry | Series C | 30M |
| 3/2022 | Qihe Biotech | Seed Round | - |
| 2/2019 | SinoMab Bioscience | Venture Round | - |
| 11/2019 | Akeso Biopharma | Series D | 150M |
| 5/2019 | Yachuang Medical | Angel Round | - |
| 9/2022 | LinkZill | Seed Round | - |
| 1/2019 | Jiuxin Medical | Series A | 3M |
| 7/2021 | GRIT Biotechnology | Series A | - |
| 1/2019 | Tavotek Biotherapeutics | Series A | - |
| 8/2020 | Shenqi Medical | Series C | 14.5M |
| 8/2022 | Axiata Bio | Series A | 13.3M |
| 11/2020 | GensKey | Series C | 0 |
| 3/2021 | Forerunner Medical | Series B | 0 |
| 1/2019 | Jiuxin Medical | Series A | - |
| 8/2016 | Ambrx | Venture Round | 0 |
| 8/2021 | Etern | Series B | - |
| 3/2021 | Medilink Therapeutics | Series A | 50M |
| 8/2022 | Axiata Bio | Series A | 0 |
| 8/2021 | Etern | Series B | - |
| 7/2021 | GRIT Biotechnology | Series A | - |
| 3/2021 | Forerunner Medical | Series B | 0 |
| 3/2021 | Medilink Therapeutics | Series A | 0 |
| 11/2020 | GensKey | Series C | 0 |
| 8/2020 | Shenqi Medical | Series C | 0 |
| 8/2020 | Jabrehoo Med Tech | Series B | 0 |
| 6/2020 | Immvira | Series B | 0 |
| 11/2019 | Akeso Biopharma | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
